IQVIA IQV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $16.63B+7.3% | $16.31B+5.9% | $15.9B+3.8% | $15.7B+3.6% | $15.5B+2.8% | ||
| $11.15B+10.2% | $10.88B+8.5% | $10.53B+6.1% | $10.32B+5.0% | $10.12B+3.3% | ||
| $1.99B+0.1% | $2B+0.4% | $1.98B-5.3% | $1.99B-4.0% | $1.99B-2.7% | ||
| $1.17B+4.7% | $1.14B+2.7% | $1.13B+0.3% | $1.12B-2.1% | $1.12B-1.8% | ||
| $127M+49.4% | $105M+47.9% | $81M-8.0% | $89M-1.1% | $85M+3.7% | ||
| $2.2B+0.4% | $2.18B-0.9% | $2.18B+5.0% | $2.18B+8.5% | $2.19B+8.9% | ||
| 13.2%-0.9pp | 13.4%-0.9pp | 13.7%+0.2pp | 13.9%+0.6pp | 14.1%+0.8pp | ||
| $756M+13.0% | $729M+8.8% | $707M+4.0% | $688M-0.4% | $669M-4.0% | ||
| $44M-6.4% | $45M-4.3% | $45M-6.3% | $45M-8.2% | $47M+14.6% | ||
| $110M+27.9% | $99M+10.0% | $83M+40.7% | $8M-94.2% | $86M-1.1% | ||
| $41M+920% | $22M+340% | -$9M-50.0% | -$8M-300% | -$5M-400% | ||
| -$2M+50.0% | -$6M— | -$4M-167% | -$4M-33.3% | -$4M+11.1% | ||
| $1.6B-3.4% | $1.59B-4.7% | $1.6B+6.7% | $1.54B+2.7% | $1.65B+15.0% | ||
| $250M-20.1% | $252M-16.3% | $305M— | $294M— | $313M— | ||
| $1.39B+3.8% | $1.36B-0.9% | $1.28B-8.7% | $1.24B-13.1% | $1.33B-1.7% | ||
| 8.3%-0.3pp | 8.3%-0.6pp | 8.1%-1.1pp | 7.9%-1.5pp | 8.6%-0.4pp | ||
| $8.06+10.0% | $7.85+4.8% | $7.28-4.3% | $6.90-10.3% | $7.33+0.3% | ||
| $8.13+9.7% | $7.92+4.6% | $7.34-4.8% | $6.97-10.6% | $7.41-0.1% | ||
| 688.2M-5.6% | 695.8M-5.5% | 705.7M-4.5% | 718.2M-3.0% | 729.3M-1.8% | ||
| 682.3M-5.4% | 689.6M-5.2% | 699M-4.2% | 710.9M-2.7% | 721.3M-1.6% | ||
| $24M+14.3% | $23M+9.5% | $22M+4.8% | $21M0.0% | $21M+10.5% | ||
| -$177M-70.2% | -$180M-39.5% | -$147M+44.7% | -$135M+51.6% | -$104M+66.2% | ||
| $1.35B+0.5% | $1.34B-2.1% | $1.29B-8.4% | $1.25B-12.6% | $1.34B-1.4% | ||
| $41M+920% | $22M+340% | -$9M-50.0% | -$8M-300% | -$5M-400% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$1.03B-79.1% | ||
| -$2.2B-53.0% | -$2.31B-59.6% | -$1.51B-12.3% | -$1.56B-18.2% | -$1.44B+15.3% | ||
| $2.7B-2.1% | $2.65B-2.3% | $2.8B+8.8% | $2.62B+7.3% | $2.76B+22.5% | ||
| $110M+27.9% | $99M+10.0% | $83M+40.7% | $8M-94.2% | $86M-1.1% | ||
| $31M+63.2% | $33M+106% | $30M+114% | $26M+30.0% | $19M-13.6% | ||
| —— | —— | —— | —— | -$3M— | ||
| $1.42B-17.6% | $1.24B-7.9% | $2.18B+409% | $2.38B+539% | $1.73B+99.9% | ||
| $41M+486% | $43M+4,200% | $36M+16.1% | $36M+12.5% | $7M— | ||
| $1.62B+122% | $1.71B+133% | $884M+34.8% | $829M+27.0% | $727M-27.3% | ||
| $588M-1.8% | $603M+0.2% | $593M-3.9% | $607M-1.0% | $599M-4.9% | ||
| $5.13B+158% | $6.47B— | $3.99B+44.9% | $3.99B— | $1.99B— | ||
| $3.65B+117% | $3.38B+100% | $2.38B+124% | $2.19B+82.1% | $1.69B-22.8% | ||
| —— | —— | —— | —— | —— | ||
| $3.75B+447% | $3.4B+254% | $2.38B+81.3% | $2.08B+37.4% | $685M-76.2% | ||
| $16.63B+7.3% | $16.31B+5.9% | $15.9B+3.8% | $15.7B+3.6% | $15.5B+2.8% | ||
| $240M+8.1% | $247M+19.9% | $235M+15.8% | $234M+19.4% | $222M+12.1% | ||
| $2.35B+1.3% | $2.32B-0.8% | $2.31B+5.8% | $2.23B+1.7% | $2.32B+8.8% | ||
| $3.52B+2.4% | $3.46B+0.3% | $3.44B+3.9% | $3.35B+0.4% | $3.44B+5.1% | ||
| $3.52B+2.4% | $3.46B+0.3% | $3.44B+3.9% | $3.35B+0.4% | $3.44B+5.1% | ||
| 21.2%-1.0pp | 21.2%-1.2pp | 21.6%0.0pp | 21.3%-0.7pp | 22.2%+0.5pp | ||
| $2.35B+1.3% | $2.32B-0.8% | $2.31B+5.8% | $2.23B+1.7% | $2.32B+8.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is IQVIA's revenue?
- IQVIA (IQV) generated $16.6B in revenue over the trailing twelve months, up 7.3% year over year.
- Is IQVIA profitable?
- IQVIA reported $1.4B in net income over the trailing twelve months, a 8.3% net margin.
- What are IQVIA's profit margins?
- Gross margin is 33.0% and operating margin is 13.2%, with a 8.3% net margin.
- What is IQVIA's earnings per share?
- IQVIA's diluted EPS over the trailing twelve months is $8.06.
- Where does IQVIA's income statement data come from?
- Every line is extracted from IQVIA's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
